IMPACT THERAP-B 07630Hong Kong Stock Exchange

12.6800.16%( -0.020 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
IMPACT THERAP-B (07630) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
IMPACT Therapeutics Inc.
Market
HKEX Main Board
Listing Date
2026-05-13
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007LG4

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)44.86M99/112
Net Profit (Last FY)-347.02M96/125

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
蔡遂雄 Executive Director
田野 Executive Director
马宁 Executive Director
徐聪 Non-Executive Director
Qiang XU Non-Executive Director
刘涛 Non-Executive Director
郭明 Independent Non-Executive Director
萧志雄 Independent Non-Executive Director
邵黎明 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-05-12.

About this page

This page shows IMPACT THERAP-B (07630) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.